Circulating MicroRNAs Biomarkers or Mediators of Cardiovascular Diseases?

被引：293

作者：

Fichtlscherer, Stephan ^{[2
]}

Zeiher, Andreas M. ^{[2
]}

Dimmeler, Stefanie ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany

[2] Goethe Univ Frankfurt, Div Cardiol, Dept Med 3, D-60590 Frankfurt, Germany

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2011年 / 31卷 / 11期

基金：

欧洲研究理事会;

关键词：

acute coronary syndromes; diabetes mellitus; biomarker; microRNAs; CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; VASCULAR INTEGRITY; MONONUCLEAR-CELLS; GENE-EXPRESSION; ANGIOGENESIS; PLASMA; SERUM;

D O I：

10.1161/ATVBAHA.111.226696

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

MicroRNAs (miRs) are small, noncoding RNAs that posttranscriptionally control gene expression by inhibiting protein translation or inducing target mRNA destabilization. Besides their intracellular function, recent studies demonstrate that miRs can be exported or released by cells and circulate with the blood in a remarkably stable form. The discovery of circulating miRs opens up intriguing possibilities to use the circulating miR patterns as biomarker for cardiovascular diseases. Cardiac injury as it occurs after acute myocardial infarction increases the circulating levels of several myocardial-derived miRs (eg, miR-1, miR-133, miR-499, miR-208), whereas patients with coronary artery disease or diabetes showed reduced levels of endothelial-enriched miRs, such as miR-126. This review article summarizes the current clinical and experimental studies addressing the role of circulating miRs as a diagnostic or prognostic biomarker in cardiovascular disease. In addition, the mechanisms by which miRs are released and their putative function as long-distance communicators are discussed. (Arterioscler Thromb Vasc Biol. 2011;31:2383-2390.)

引用

页码：2383 / 2390

页数：8

共 59 条

[1] Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction [J].

Adachi, Taichi ;

Nakanishi, Michio ;

Otsuka, Yoritaka ;

Nishimura, Kunihiro ;

Hirokawa, Gou ;

Goto, Yoichi ;

Nonogi, Hiroshi ;

Iwai, Naoharu .

CLINICAL CHEMISTRY, 2010, 56 (07) :1183-1185

[2] Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction [J].

Ai, Jing ;

Zhang, Rong ;

Li, Yue ;

Pu, Jielin ;

Lu, Yanjie ;

Jiao, Jundong ;

Li, Kang ;

Yu, Bo ;

Li, Zhuqin ;

Wang, Rongrong ;

Wang, Lihong ;

Li, Qiang ;

Wang, Nina ;

Shan, Hongli ;

Li, Zhongyu ;

Yang, Baofeng .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) :73-77

[3] Microparticles: Key Protagonists in Cardiovascular Disorders [J].

Amabile, Nicolas ;

Rautou, Pierre-Emmanuel ;

Tedgui, Alain ;

Boulanger, Chantal M. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (08) :907-916

[4] Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].

Arroyo, Jason D. ;

Chevillet, John R. ;

Kroh, Evan M. ;

Ruf, Ingrid K. ;

Pritchard, Colin C. ;

Gibson, Donald F. ;

Mitchell, Patrick S. ;

Bennett, Christopher F. ;

Pogosova-Agadjanyan, Era L. ;

Stirewalt, Derek L. ;

Tait, Jonathan F. ;

Tewari, Muneesh .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008

[5] Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease [J].

Besler, Christian ;

Heinrich, Kathrin ;

Rohrer, Lucia ;

Doerries, Carola ;

Riwanto, Meliana ;

Shih, Diana M. ;

Chroni, Angeliki ;

Yonekawa, Keiko ;

Stein, Sokrates ;

Schaefer, Nicola ;

Mueller, Maja ;

Akhmedov, Alexander ;

Daniil, Georgios ;

Manes, Costantina ;

Templin, Christian ;

Wyss, Christophe ;

Maier, Willibald ;

Tanner, Felix C. ;

Matter, Christian M. ;

Corti, Roberto ;

Furlong, Clement ;

Lusis, Aldons J. ;

von Eckardstein, Arnold ;

Fogelman, Alan M. ;

Luescher, Thomas F. ;

Landmesser, Ulf .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2693-2708

[6] A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer [J].

Bianchi, Fabrizio ;

Nicassio, Francesco ;

Marzi, Matteo ;

Belloni, Elena ;

Dall'Olio, Valentina ;

Bernard, Loris ;

Pelosi, Giuseppe ;

Maisonneuve, Patrick ;

Veronesi, Giulia ;

Di Fiore, Pier Paolo .

EMBO MOLECULAR MEDICINE, 2011, 3 (08) :495-503

[7] Vascular microRNAs [J].

Bonauer, Angelika ;

Boon, Reinier A. ;

Dimmeler, Stefanie .

CURRENT DRUG TARGETS, 2010, 11 (08) :943-949

[8] MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice [J].

Bonauer, Angelika ;

Carmona, Guillaume ;

Iwasaki, Masayoshi ;

Mione, Marina ;

Koyanagi, Masamichi ;

Fischer, Ariane ;

Burchfield, Jana ;

Fox, Henrik ;

Doebele, Carmen ;

Ohtani, Kisho ;

Chavakis, Emmanouil ;

Potente, Michael ;

Tjwa, Marc ;

Urbich, Carmen ;

Zeiher, Andreas M. ;

Dimmeler, Stefanie .

SCIENCE, 2009, 324 (5935) :1710-1713

[9] Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway [J].

Brock, Matthias ;

Trenkmann, Michelle ;

Gay, Renate E. ;

Michel, Beat A. ;

Gay, Steffen ;

Fischler, Manuel ;

Ulrich, Silvia ;

Speich, Rudolf ;

Huber, Lars C. .

CIRCULATION RESEARCH, 2009, 104 (10) :1184-U139

[10] miRNAs as serum biomarkers for Duchenne muscular dystrophy [J].

Cacchiarelli, Davide ;

Legnini, Ivano ;

Martone, Julie ;

Cazzella, Valentina ;

D'Amico, Adele ;

Bertini, Enrico ;

Bozzoni, Irene .

EMBO MOLECULAR MEDICINE, 2011, 3 (05) :258-265

← 1 2 3 4 5 6 →